Clinical Trial Update: A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating natalizumab for moderately to severely active Crohn's disease has completed. The update notes completion but does not provide efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED